Mrs Claire Lucas PhD

Scientist and Honorary Lecturer Molecular & Clinical Cancer Medicine

    Research

    CIP2A



    Currently my research work is focusing on CIP2A biology in both CML and AML. My current research can be outlined in four themes, 1. Identifying novel CIP2A binding partners. 2. Validating CIP2A as a biomarker of clinical outcome in the UK SPIRIT 2 clinical trial. 3. Does CIP2A predict clinical outcome in AML- manuscript in preparation for leukemia, and the importance of the CIP2A/AKT pathway in AML. 4. CIP2A regulation of BCL2 family members in AML and CML.

    Research Grants

    Work completed on the feasibility of the BCR-ABL assay to determine the presence of fusion proteins in plasma samples at diagnosis

    BD BIOSCIENCES EUROPE (BELGIUM)

    August 2010 - July 2014